The Use of Amber Glasses in Improving Sleep
NCT04751019 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2021-02-11
Summary
The use of amber glasses will aid the patient to fall asleep without the need for the use of hypnotic medication.
Conditions
- Sleep Disturbance
- Insomnia
Interventions
- DEVICE
-
Amber Glasses
It is hoped that the use of amber glasses to complement the natural sleep-wake by inducing a perceived 'physiological darkness' to aid the secretion of melatonin should help sleep and reduce the use of hypnotic medication
Sponsors & Collaborators
-
Surrey and Borders Partnership NHS Foundation Trust
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-03-11
- Primary Completion
- 2020-01-31
- Completion
- 2020-01-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Efficacy and Safety of Tasimelteon Compared With Placebo in Totally Blind Subjects With Non-24-Hour Sleep-Wake Disorder
NCT01163032 ·Status: COMPLETED ·Phase: PHASE3
-
Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia
NCT00280423 ·Status: COMPLETED ·Phase: PHASE2
-
SleepSure: A Trial to Assess the Effects of Eye Masks and Earplugs on Hospital Inpatient Sleep
NCT02732912 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of ACT-541468 in Elderly Subjects With Insomnia Disorder
NCT02841709 ·Status: COMPLETED ·Phase: PHASE2
-
Non-pharmacological Treatment of Insomnia in Nursing Homes.
NCT01091987 ·Status: COMPLETED ·Phase: NA
-
Almorexant (ACT-078573) in Elderly Subjects With Chronic Primary Insomnia
NCT00606593 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of EVT 201 in the Treatment of Elderly Patients With Daytime Sleepiness
NCT00401284 ·Status: COMPLETED ·Phase: PHASE2
-
Almorexant (ACT 078573) in Adult Subjects With Chronic Primary Insomnia
NCT00608985 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy and Safety of Circadin® 2 mg in the Treatment of Primary Insomnia Patients
NCT00397189 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Insomnia on Simulated Driving (MK-0000-183-00)
NCT01209728 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study of a Combination Drug Product for Treatment of Short-term Insomnia
NCT02671760 ·Status: COMPLETED ·Phase: PHASE2
-
Hydrogen-oxygen Mixed Gas in the Treatment of Insomnia
NCT05248360 ·Status: UNKNOWN ·Phase: NA
-
Safety, Tolerability and Efficacy Study of V117957 in Subjects With Insomnia Associated With Alcohol Cessation
NCT04035200 ·Status: COMPLETED ·Phase: PHASE2
-
Tasimelteon for the Treatment of Non-24-hour Sleep-Wake Disorder (N24HSWD) in Blind Individuals With no Light Perception
NCT01429116 ·Status: COMPLETED ·Phase: PHASE3
-
An Investigational Study to Assess Efficacy and Pattern of Use of SM-1 in Subjects With a History of Transient Insomnia
NCT03338764 ·Status: WITHDRAWN ·Phase: PHASE3
-
Modulation of Sleep Perception Through Auditory Closed-loop Stimulation of Brain Oscillatory Activity
NCT04276064 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate the Effect of 2 Dosage Strengths of Lemborexant (E2006) on a Multiple Sleep Latency Test in Participants With Insomnia Disorder
NCT02350309 ·Status: COMPLETED ·Phase: PHASE1
-
Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder
NCT01430754 ·Status: COMPLETED ·Phase: PHASE3
-
Solriamfetol and CBT-I in Patients With Insomnia Disorder
NCT05838430 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Countermeasures on Nocturnal Driving Performance
NCT01070004 ·Status: COMPLETED ·Phase: NA
-
Management of Insomnia in Breast Cancer Patients
NCT01011218 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy Study of EVT 201 to Treat Insomnia
NCT00380003 ·Status: COMPLETED ·Phase: PHASE2
-
Study of an Evening Dose of Eszopiclone on Next Day Driving Ability & Psychomotor/Memory Function in Healthy Volunteers
NCT00368160 ·Status: COMPLETED ·Phase: PHASE1
-
Combined Behavioral/Pharmacological Therapy for Insomnia
NCT00044629 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of ACT-541468 in Adult Subjects With Insomnia Disorder
NCT02839200 ·Status: COMPLETED ·Phase: PHASE2